Teneligliptin and “Thorough QTc study”: thorough enough?
Samit GhosalDepartment of Endocrinology, Nightingale Hospital, Kolkata, IndiaI read with interest the “Thorough QTc study” with teneligliptin by Erande et al.1 It came as a surprise to me that the basic structure required to conduct such a trial as per the ICH E...
Guardado en:
Autor principal: | Ghosal S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e0bb67106fff4eed93e4707707127c4c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
QT/QTc safety and efficacy evaluation of teneligliptin in Indian type 2 diabetes mellitus patients: the “thorough QT/QTc” study (Q-SET study)
por: Erande S, et al.
Publicado: (2019) -
Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes
por: Kishimoto M
Publicado: (2013) -
Teneligliptin in management of type 2 diabetes mellitus
por: Sharma SK, et al.
Publicado: (2016) -
Teneligliptin real-world efficacy assessment of type 2 diabetes mellitus patients in India (TREAT-INDIA study)
por: Ghosh S, et al.
Publicado: (2016) -
Is insulin degludec a more effective treatment for patients using high doses of insulin glargine but not attaining euglycemia? Some case reports from India
por: Sinha B, et al.
Publicado: (2014)